IUPAC NAME-2-{[(E)-{5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethanamine
MOLECULAR FORMULA-C15H21F3N2O2
MOLAR MASS-318.335
There is some evidence that fluvoxamine may be a helpful adjunct in the treatment of schizophrenia, improving the depressive, negative and cognitive symptoms of the disorder. Its actions at the sigma receptor may afford it a unique advantage among antidepressants in treating the cognitive symptoms of schizophrenia.
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Formulation such as Tablets, Capsules, Liquid and semisolid Preparations and marketing of Quality Products in Domestic. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, cardiology, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. Also deals with trading o...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$1 Million - US$2.5 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 98
Number of QC Staff: 21 - 30 People
Total Annual Sales Volume: US$2.5 Million - US$5 Million
India
Germany 
Hong kong 